Accendra Health (ACH) Liabilities and Shareholders Equity (2009 - 2026)

Accendra Health (ACH) has reported Liabilities and Shareholders Equity for 18 consecutive years, with $2.4 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 50.25% year-over-year to $2.4 billion; the TTM figure through Mar 2026 stood at $13.1 billion (down 34.37% YoY), while the FY2025 annual figure was $2.5 billion, down 47.34% from the prior year.
• Liabilities and Shareholders Equity retreated to $2.4 billion in Q1 2026 per ACH's latest filing, from $2.5 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $5.7 billion in Q1 2022 and bottomed at $2.4 billion in Q1 2026.
• Historically, Liabilities and Shareholders Equity has averaged $4.8 billion across 5 years, with a median of $5.1 billion in 2023.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 68.34% — and 2026, when it tumbled 50.25%.
• Accendra Health's Liabilities and Shareholders Equity stood at $5.4 billion in 2022, then retreated by 5.44% to $5.1 billion in 2023, then retreated by 8.58% to $4.7 billion in 2024, then plunged by 47.34% to $2.5 billion in 2025, then retreated by 1.46% to $2.4 billion in 2026.
• Business Quant data shows ACH's Liabilities and Shareholders Equity at $2.4 billion in Q1 2026, $2.5 billion in Q4 2025, and $4.0 billion in Q3 2025.